Evidence map›Paper›PMID 28667181›Full record

ArticleNeurology2017

Sarah von Spiczak, Katherine L Helbig, Deepali N Shinde, Robert Huether, Manuela Pendziwiat, Charles Lourenço, Mark E Nunes, Dean P Sarco, Richard A Kaplan, Dennis J Dlugos and 29 more

Open access · hybridAbstract read
In one paragraph

Article in Neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Genetic medicines for epilepsy: unlocking new avenues for seizure control.Frontiers in bioengineering and biotechnology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Deep Brain Stimulation in Leigh-Like Syndrome Due to DNM1 Pathogenic Variant.Tremor and other hyperkinetic movements (New York, N.Y.) · 2025
    Article
  13. Article
  14. Review
  15. Clinical trials for Lennox-Gastaut syndrome: Challenges and priorities.Annals of clinical and translational neurology · 2024
    Review
  16. Effective knockdown-replace gene therapy in a novel mouse model of DNM1 developmental and epileptic encephalopathy.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 2 institutions in 2 countries.

Sarah von SpiczakAuthor affiliations are provided at the end of the article.
Katherine L HelbigAuthor affiliations are provided at the end of the article.
Deepali N ShindeAuthor affiliations are provided at the end of the article.
Robert HuetherAuthor affiliations are provided at the end of the article.
Manuela PendziwiatAuthor affiliations are provided at the end of the article.
Charles LourençoAuthor affiliations are provided at the end of the article.
Mark E NunesAuthor affiliations are provided at the end of the article.
Dean P SarcoAuthor affiliations are provided at the end of the article.
Richard A KaplanAuthor affiliations are provided at the end of the article.
Dennis J DlugosAuthor affiliations are provided at the end of the article.
Heidi KirschAuthor affiliations are provided at the end of the article.
Anne SlavotinekAuthor affiliations are provided at the end of the article.
Maria R CilioAuthor affiliations are provided at the end of the article.
Mackenzie C CervenkaAuthor affiliations are provided at the end of the article.
Julie S CohenAuthor affiliations are provided at the end of the article.
Rebecca McClellanAuthor affiliations are provided at the end of the article.
Ali FatemiAuthor affiliations are provided at the end of the article.
Amy YuenAuthor affiliations are provided at the end of the article.
Yoshimi SagawaAuthor affiliations are provided at the end of the article.
Rebecca LittlejohnAuthor affiliations are provided at the end of the article.
Scott D McLeanAuthor affiliations are provided at the end of the article.
Laura Hernandez-HernandezAuthor affiliations are provided at the end of the article.
Bridget MaherAuthor affiliations are provided at the end of the article.
Rikke S MøllerAuthor affiliations are provided at the end of the article.
Elizabeth PalmerAuthor affiliations are provided at the end of the article.
John A LawsonAuthor affiliations are provided at the end of the article.
Colleen A CampbellAuthor affiliations are provided at the end of the article.
Charuta N JoshiAuthor affiliations are provided at the end of the article.
Diana L KolbeAuthor affiliations are provided at the end of the article.
Georgie HollingsworthAuthor affiliations are provided at the end of the article.
Bernd A NeubauerAuthor affiliations are provided at the end of the article.
Hiltrud MuhleAuthor affiliations are provided at the end of the article.
Ulrich StephaniAuthor affiliations are provided at the end of the article.
Ingrid E SchefferAuthor affiliations are provided at the end of the article.
Sérgio D J PenaAuthor affiliations are provided at the end of the article.
Sanjay M SisodiyaAuthor affiliations are provided at the end of the article.
Ingo HelbigAuthor affiliations are provided at the end of the article. helbigi@email.chop.edu.
Epi4K Consortium
EuroEPINOMICS-RES NLES Working Group
School of the Art Institute of Chicago · USSchneider Electric (France) · FR

Funding

3 of 7 Epi4K: Sequencing, Biostatistics & Bioinformatics CoreU01NS077303 · NINDS · DUKE UNIVERSITY · PI EICHLER, EVAN, GOLDSTEIN, DAVID B. · 2011 to 2018
$13.3M
ClinGen Expert Curation Panel for the EpilepsiesU24NS120854 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Ingo Helbig, HEATHER C. MEFFORD · 2021 to 2026
$2.0M
NINDS NIH HHS U01 NS077303NINDS NIH HHS U24 NS120854Wellcome Trust
6 · The paper itself

Abstract

objectiveTo evaluate the phenotypic spectrum caused by mutations in dynamin 1 (

methodsWe reviewed phenotypic data of 21 patients (7 previously published) with

resultsWe identified 19 patients with de novo mutations in

conclusionsThe phenotypic spectrum of

Indexed as

MutationAdolescentBrain DiseasesChildChild, PreschoolCohort StudiesDNA Mutational AnalysisDynaminsFemaleGTP PhosphohydrolasesHomeodomain ProteinsHumansInfantMaleMicrotubule-Associated ProteinsMitochondrial ProteinsDNM1L protein, humanDynaminsGTP PhosphohydrolasesHomeodomain ProteinsMicrotubule-Associated ProteinsMitochondrial ProteinsShort Stature Homeobox ProteinSHOX protein, human

Identifiers

PMID28667181
PMCPMC5574673
OpenAlexW2732466682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.